# SCRIMED p.33 Review Packet

Candidate binding: generated source manifest and release tooling must replace this preparation state with the exact final commit and fingerprints after all local validation passes.

## Change Scope

The candidate integrates one p.33 layer into the existing SCRIMED control plane. It does not create a competing runtime, policy engine, model registry, or audit system. The implementation composes existing p.32 context, governance, agent, model qualification, imaging, oncology, network, Product Console, claims, evidence, release, and observability controls.

## Risk Classification

Overall: high review significance, low current operational blast radius.

Reason: the code defines clinical-context, evidence, oversight, and pilot eligibility policy, but executes only deterministic synthetic fixtures with external actions disabled. Incorrect policy could affect future activation decisions, so independent technical, clinical-safety, security/privacy, claims/legal, and platform review is required.

## Review Lanes

Technical reviewer:

- Contract correctness and API integration
- Unicode offset correctness
- Determinism and idempotency
- Test completeness and performance

Clinical-safety reviewer:

- Context retention, omissions, contradictions, uncertainty, medication/dose warnings
- Extraction release-gate floors
- Regulatory Label intended and excluded uses
- Oversight cohort and review-rate policy
- ClinicalTrajectory contraindication and omission scoring

Security/privacy reviewer:

- Cross-tenant denial and revocation
- No raw PHI, secrets, prompts, or hidden reasoning in evidence
- Local worker filesystem/network/tool/resource controls
- Restricted pilot bypass resistance
- Decision-ledger tamper evidence

Claims/legal reviewer:

- Opportunity module boundaries
- Investor-deck claim manifest
- Legal and actuarial disclaimers
- Absence of unverified customers, outcomes, funding, partnerships, certifications, and regulatory claims

Platform reviewer:

- Provider-neutral route policy
- Safe refusal and fallback behavior
- Product Console and control-plane payload impact
- Feature-flag defaults and rollback

Founder/counsel/finance:

- Exact investor artifact fingerprint
- External distribution decision
- Business and financial narrative
- No relationship, endorsement, or partnership implication

## Required Validation Evidence

- `scripts/scrimed-p33-integrated-policy-test.mjs`
- `scripts/scrimed-p33-integrated-contract-check.mjs`
- `artifacts/p33/P33_VALIDATION_REPORT.json`
- Full nonsecret suite
- Typecheck, lint, production build, generated integrity, secret scan, SBOM
- Public smoke and desktop/390px browser checks
- Exact candidate/review/gate fingerprints

## Measured Local Surface

- `/scrimed-p33`: rendered at 1280px and 390px with no horizontal overflow or console warnings.
- Six p.33 control-plane endpoints: HTTP 200 from the local production build.
- `/api/product/console`: HTTP 200, 775,065-byte response, retaining compact p.33 summary fields.
- Internal investor deck: 12 slides, SHA-256 `b042b32834de48bceb337d8b33fe14242ca7bff8869722ca41e096b75999b4b9`; strict automated review passed.

These results are local synthetic evidence. They do not establish clinical validation, production readiness, external distribution authority, or customer activation.

## Approval Fields

- Reviewer identity: pending
- Reviewer role: pending
- Exact commit: pending final local commit
- Exact candidate fingerprint: pending final candidate generation
- Decision: OPERATOR_REQUIRED
- Conditions: none recorded
- Timestamp: pending
- Expiration: pending

No reviewer field may be completed by the implementing agent.
